NEW YORK (TheStreet) -- It's been 50 years since the Beatles stormed the U.S., and Beatlemania is making an anniversary comeback. The Beatles have been honored in a special Grammys ceremony, on Apple's (AAPL) iTunes, and in re-releases like Vivendi's (VIVHY) The Beatles: U.S. Albums. (Not that the Beatles ever really disappeared, either.)
Now the Beatles' quasi-autobiographical film, A Hard Day's Night, will be screening again in theaters. Originally released by United Artists (now MGM) and directed by Richard Lester, the film has been remastered by Janus Films' Criterion Collection in 4K Ultra HD video and in 5.1 surround-sound audio. The film will be widely re-released mainly to art-house theaters. For a full listing of screenings, take a look at the Janus Films Web site.
Top 5 Warren Buffett Companies To Buy For 2015: The Navigators Group Inc.(NAVG)
The Navigators Group, Inc., together with its subsidiaries, engages in underwriting ocean marine, property and casualty, professional liability, and specialty insurance products and services. The company?s marine and inland marine insurance products include marine and energy liability, cargo, craft/fishing vessel, bluewater hull, brownwater hull, protection and indemnity, war, customs bonds, commercial output policy, construction, transportation, specialty, specie, and marine excess-of-loss reinsurance Its property and casualty insurance products comprise general and environmental liability, umbrella and excess, offshore energy, onshore energy, operational engineering, construction, life sciences, exporters package liability, accident and health reinsurance, Latin America property and casualty reinsurance, agriculture reinsurance, professional liability reinsurance, bloodstock, and the U.S. casualty insurance products. The company?s professional liability products inclu de directors and officers, employment practices, fiduciary, crime, accountants professional, lawyers professional, insurance agent errors and omissions, miscellaneous professional, technology and media, design professionals, and real estate agent liability insurance products. The Navigators Group, Inc. distributes its products through global, national, and regional retail and wholesale insurance brokers. The company was founded in 1981 and is based in Rye Brook, New York.
Advisors' Opinion:- [By Ben Levisohn]
Tower Group has dropped 40% to $4.43 today, and some other small insurers are also getting dinged this morning. HCI Group (HCI) has fallen 1.8% to $39.36, Stewart Information Services (STC) has declined 0.7% to $31.36 and the Navigators Group (NAVG) has ticked down 0.4% to $56.10.
- [By CRWE]
The Navigators Group, Inc. (NASDAQ:NAVG) reported that its principal underwriting agency subsidiary, Navigators Management Company, Inc., has expanded Adrien T. Robinson’s responsibilities to include the open-brokerage products of Life Sciences, Global Package, Environmental Casualty, Commercial Auto and Excess Casualty Retail. Mr. Robinson was previously President of the Environmental Casualty division.
Best High Tech Stocks To Invest In 2014: Nevada Gold Corp (NVGC)
Nevada Gold Corp., incorporated on May 31, 2011, is an exploration-stage company. The Company is primarily engaged in the acquisition and exploration of mining properties.
The Company has an option to acquire certain claims located the Long Canyon Gold Trend of Northern Nevada State. As of February 28, 2013, the Company had no revenue.
Advisors' Opinion:- [By John Udovich]
Small cap OTC stocks Sovereign Lithium Inc (OTCMKTS: SLCO), Life Stem Genetics Inc (OTCMKTS: LIFS), Nevada Gold Corp (OTCMKTS: NVGC), Guar Global Ltd (OTCMKTS: GGBL) and Makism 3D Corp (OTCMKTS: MDDD) all saw their trading halted late last year by the SEC, but now all of these stocks are trading again. So what's going on and why the sudden crackdown? First, here is a quick look at what happened to the following five small cap stocks:
Best High Tech Stocks To Invest In 2014: Nestle SA (NESN.VX)
Nestle SA is a Swiss Company engaged in the nutrition, health and wellness sectors. It is the holding company of the Nestle Group, which comprises subsidiaries, associated companies and joint ventures throughout the world. It has such business units as Food and Beverage, Nestle Waters and Nestle Nutrition. It is also active in the pharmaceutical sector. It divides its products into Powdered and liquid beverages, Water, Milk products and Ice cream, Nutrition, Prepared dishes and cooking aids, Confectionery, PetCare and Pharmaceutical products. In February 2011, the Company acquired CM&D Pharma Ltd.
Advisors' Opinion:- [By Michael Calia]
Post Holdings Inc.(POST) agreed to acquire the PowerBar and Musashi brands from Nestle SA(NESN.VX), further expanding the cereal maker’s position in the active nutrition category.
Best High Tech Stocks To Invest In 2014: Carmike Cinemas Inc.(CKEC)
Carmike Cinemas, Inc. operates as a digital cinema and 3D motion picture exhibitor in the United States. It operates theatres that show films on a first-run basis; and discount theatres. The company serves small to mid-size non-urban markets. As of December 31, 2011, it owned, operated, or had an interest in 237 theatres with 2,254 screens located in 35 states. The company was founded in 1982 and is headquartered in Columbus, Georgia.
Advisors' Opinion:- [By Chad Fraser] Christmas is a time for good cheer, reflection and spending time with friends and family. Here are four stocks that reflect the season, ranging from Christmas tree providers to toymakers and beyond:
Weyerhaeuser (NYSE: WY): Some little-known Christmas tree facts: there are 25 million to 30 million sold in the U.S. every year, with about 350 million currently growing in the country. It takes an average of seven years to grow a Christmas tree to its proper height.
Most Christmas tree farms are privately owned, but they need to get good seedlings from somewhere, so many turn to timber company Weyerhaeuser, which grows the most popular species—including balsam fir, Douglas fir, Scotch pine and white pine.
Weyerhaeuser controls about 6 million acres of timberland, with about a third of that in the Pacific Northwest, which is America’s most prolific lumber-producing region thanks to its cool, damp climate and considerable rainfall.
“The fact that it’s the largest timber producer in the Pacific Northwest makes Weyerhaeuser extremely attractive, because the company’s location gives it easy export access to China,” wrote Investing Daily analyst Benjamin Shepherd in a December 13 article. “This location also leaves it well-placed to pick up the supply slack created by lower production caps in Canada, which is typically a key Chinese supplier.”
Mattel (NYSE: MAT) is proving that the most traditional toys you can think of—dolls—still have a place under the tree, even in the digital age. As we reported on October 16, Mattel’s doll lineup was the main reason why its third-quarter earnings surged past Wall Street estimates.
The company’s strength is centered on its ability to come up with popular new dolls while reimagining the tried-and-true. Right now, its Monster High franchise, which it rolled out in 2010, is stealing the show: the brand’s p - [By John Udovich]
The shares of small cap IMAX Corporation (NYSE: IMAX) have slipped more than 10% this week on growth concerns - meaning it might be a good idea to take a closer look at the stock plus its performance�verses other cinema stocks like Carmike Cinemas, Inc (NASDAQ: CKEC), Cinemark Holdings, Inc (NYSE: CNK) and Regal Entertainment Group (NYSE: RGC) along with the PowerShares Dynamic Leisure & Entertainment ETF�(NYSEARCA: PEJ).
Best High Tech Stocks To Invest In 2014: Madison Square Garden Inc.(MSG)
The Madison Square Garden Company, together with its subsidiaries, operates in the sports, entertainment, and media businesses primarily in the United States. The company operates in three segments: MSG Media, MSG Entertainment, and MSG Sports. The MSG Media segment produces and develops content for various distribution platforms, including content originating from the company?s venues. It consists of the MSG Networks and the Fuse Networks, which offer sports and musical content. This segment also manages interactive businesses that comprise a range of targeted websites; and wireless, video on demand, and digital platforms. The MSG Entertainment segment creates, produces, and/or presents various live productions, as well as presents or hosts other live entertainment events, such as concerts, family shows, special events, and theatrical productions. The MSG Sports segment owns and operates sports franchises. This segment also owns other sports properties, including the pre sentation of a range of live sporting events, such as professional boxing, college basketball, track and field, and tennis. The company owns the Madison Square Garden complex in New York City, which includes an arena and a theater; and The Chicago Theatre in Chicago. It leases Radio City Music Hall and the Beacon Theatre in New York City. The company is based in New York, New York. As of February 09, 2010, Madison Square Garden, Inc. operates independently of Cablevision Systems Corporation.
Advisors' Opinion:- [By Ben Levisohn]
Madison Square Garden�(MSG) gained 1.3% to $65.91 in after-hours trading on Friday after�JAT Capital Management�reported that it had�taken a 6.7% stake�in the owner of the New York Knicks and would push it to create more value for shareholders.
- [By Jayson Derrick]
Analysts at ISI Group downgraded The Madison Square Garden Company (NYSE: MSG) to Neutral from Buy. Shares hit new 52-week highs of $65.57 before closing the day at $65.08.
- [By Ben Levisohn]
Another important component of overcrowding is that current volatility tends to be low, and underestimates the amount of risk in the stock, Zlotnikov says. He offers a list of low-beta stocks that screened for overcrowding characteristics. They include Walt Disney (DIS), Ecolab (ECL), Walgreen (WAG), McKesson (MCK) and Madison Square Garden (MSG), among others.
Best High Tech Stocks To Invest In 2014: Gilead Sciences Inc.(GILD)
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fost er City, California.
Advisors' Opinion:- [By Melvin Backman]
But Olysio is just one part of a common treatment and is typically prescribed with Gilead Science' (GILD)s Sovaldi drug. Gilead is working on an Olysio replacement that will render Olysio's continued growth unsustainable, according to Royal Bank of Canada's Glenn Novarro.
No comments:
Post a Comment